Scientists test mRNA tech in new push for an HIV vaccine

NCT ID NCT05217641

Ongoing ⭐️ VACCINE ⭐️ Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Source: ClinicalTrials.gov ↗

Summary

This is an early-stage study to check the safety and immune response of three new experimental mRNA vaccines designed to prevent HIV. The study will enroll 108 healthy, HIV-negative adults to receive injections and be closely monitored for side effects. The main goal is to see if the vaccines are safe and can trigger the body to produce antibodies that might fight off HIV.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Alabama CRS [31788]

Birmingham, Alabama, 35222, United States
Bidmc Vcrs [32077]

Boston, Massachusetts, 02115, United States
Brigham and Women's Hospital Vaccine CRS [30007]

Boston, Massachusetts, 02115, United States
Columbia P&S CRS [30329]

New York, New York, 30329, United States
New York Blood Center CRS [31801]

New York, New York, 10065, United States
Penn Prevention CRS [30310]

Philadelphia, Pennsylvania, 19104, United States
Seattle Vaccine and Prevention CRS [30331]

Seattle, Washington, 98104, United States
UCLA Vine Street Clinic CRS [31607]

Los Angeles, California, 90038, United States
University of Pittsburgh CRS [1001]

Pittsburgh, Pennsylvania, 15213, United States
University of Rochester Vaccines to Prevent HIV Infection CRS [31467]

Rochester, New York, 14642, United States

Conditions

Explore the condition pages connected to this study.

HIV INFECTIONS